Criteria for identifying residual tumours after neoadjuvant chemotherapy of breast cancers: a magnetic resonance imaging study

Criteria for identifying residual tumours after neoadjuvant chemotherapy of breast cancers: a magnetic resonance imaging study

Abstract We investigated magnetic resonance imaging (MRI) criteria identifying residual tumours in patients with triple-negative and human epidermal growth factor receptor type 2-positive (HER2+) breast cancer following neoadjuvant chemotherapy. Retrospectively, 290 patients were included who had un...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yunju Kim, Sung Hoon Sim, Boram Park, In Hye Chae, Jai Hong Han, So-Youn Jung, Seeyoun Lee, Youngmi Kwon, In Hae Park, Kyounglan Ko, Chan Wha Lee, Keun Seok Lee, Han-Sung Kang, Eun Sook Lee
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/e9e8380a776043ca99b512895ec1127e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares